FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer

FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer

Among FOS-related components of the dimeric AP-1 transcription factor, the oncoprotein FRA-1 (encoded by <i>FOSL1</i>) is a key regulator of invasion and metastasis. The well-established FRA-1 pro-invasive activity in breast cancer, in which <i>FOSL1</i> is overexpressed in t...

Full description

Bibliographic Details
Main Authors:	Laura Casalino, Francesco Talotta, Ilenia Matino, Pasquale Verde
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	International Journal of Molecular Sciences
Subjects:	AP-1 transcription factors FRA-1 <i>FOSL1</i> TNBC EMT
Online Access:	https://www.mdpi.com/1422-0067/24/9/8307

Similar Items

The Fra-1/AP-1 Oncoprotein: From the “Undruggable” Transcription Factor to Therapeutic Targeting
by: Laura Casalino, et al.
Published: (2022-03-01)

Overexpression of FRA1 (<i>FOSL1</i>) Leads to Global Transcriptional Perturbations, Reduced Cellular Adhesion and Altered Cell Cycle Progression
by: Wuroud Al-khayyat, et al.
Published: (2023-09-01)

Multiple Fra-1-bound enhancers showing different molecular and functional features can cooperate to repress gene transcription
by: Fabienne Bejjani, et al.
Published: (2023-07-01)

NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1
by: Carolina Marques, et al.
Published: (2021-08-01)

Role of the Transcription Factor FOSL1 in Organ Development and Tumorigenesis
by: Vladimir V. Sobolev, et al.
Published: (2022-01-01)

The Transcription Factor FRA-1/AP-1 Controls Lipocalin-2 Expression and Inflammation in Sepsis Model
by: Shan Cao, et al.
Published: (2021-10-01)

IGFBP2 Is a Potential Master Regulator Driving the Dysregulated Gene Network Responsible for Short Survival in Glioblastoma Multiforme
by: Manasa Kalya, et al.
Published: (2021-06-01)

The Fra-1: Novel role in regulating extensive immune cell states and affecting inflammatory diseases
by: Yu-Yao He, et al.
Published: (2022-08-01)

Fra2 Overexpression in Mice Leads to Non-allergic Asthma Development in an IL-13 Dependent Manner
by: Anna Gungl, et al.
Published: (2018-09-01)

Fra-2 Is a Dominant Negative Regulator of Natural Killer Cell Development
by: Diana Schnoegl, et al.
Published: (2022-06-01)

Effects of <i>Yersinia pestis</i> Fra-Operon Carriage on the Cellular Morphologic Features of the Recipient <i>Yersinia pseudotuberculosis</i> Strain
by: A. A. Byvalov, et al.
Published: (2008-04-01)

Alpha 1 Antitrypsin Regulates Trophoblast Syncytialization and Inflammatory Factor Expression
by: Kanoko Yoshida, et al.
Published: (2022-02-01)

ALK inhibitors downregulate the expression of death receptor 4 in ALK-mutant lung cancer cells via facilitating Fra-1 and c-Jun degradation and subsequent AP-1 suppression
by: Wen Zhao, et al.
Published: (2023-08-01)

Influence of FOSL1 Inhibition on Vascular Calcification and ROS Generation through Ferroptosis via P53-SLC7A11 Axis
by: Sisi Shao, et al.
Published: (2023-02-01)

Ubiquitin-Specific Protease 21 Promotes Colorectal Cancer Metastasis by Acting as a Fra-1 Deubiquitinase
by: Sun-Il Yun, et al.
Published: (2020-01-01)

Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion
by: Matthew G. Annis, et al.
Published: (2018-01-01)

Regulation of Inflammation-Related Genes through <i>Fosl1</i> Suppression in a Levetiracetam-Treated Pilocarpine-Induced Status Epilepticus Mouse Model
by: Rie Komori, et al.
Published: (2022-07-01)

Expression and Function of <i>C1orf132</i> Long-Noncoding RNA in Breast Cancer Cell Lines and Tissues
by: Afsaneh Malekzadeh Shafaroudi, et al.
Published: (2021-06-01)

<i>OLR1</i> Is a Pan-Cancer Prognostic and Immunotherapeutic Predictor Associated with EMT and Cuproptosis in HNSCC
by: Lei Wu, et al.
Published: (2023-08-01)

Metabolomics and EMT Markers of Breast Cancer: A Crosstalk and Future Perspective
by: Ajay Kumar Pal, et al.
Published: (2022-05-01)

Pterostilbene inhibits the metastasis of TNBC via suppression of β-catenin-mediated epithelial to mesenchymal transition and stemness
by: Kang Ma, et al.
Published: (2022-09-01)

Inositol monophosphatase 1 (IMPA1) promotes triple‐negative breast cancer progression through regulating mTOR pathway and EMT process
by: Shao‐Ying Yang, et al.
Published: (2023-01-01)

Fra-1 and c-Fos N-Terminal Deletion Mutants Impair Breast Tumor Cell Proliferation by Blocking Lipid Synthesis Activation
by: Ana Cristina Racca, et al.
Published: (2019-06-01)

Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1
by: Li-na Song, et al.
Published: (2020-06-01)

HOXA11-AS1 Promotes PD-L1-Mediated Immune Escape and Metastasis of Hypopharyngeal Carcinoma by Facilitating PTBP1 and FOSL1 Association
by: Zheng Zhou, et al.
Published: (2022-07-01)

SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT
by: Weiwei Liu, et al.
Published: (2018-04-01)

Dexamethasone resets stable association of nuclear Snail with LSD1 concomitant with transition from EMT to partial EMT
by: Satoshi Okuda, et al.
Published: (2022-07-01)

The expression analysis of Fra-1 gene and IL-11 protein in Iranian patients with ulcerative colitis
by: Milad Sabzevary-Ghahfarokhi, et al.
Published: (2018-06-01)

Reduced <i>Zeb1</i> Expression in Prostate Cancer Cells Leads to an Aggressive Partial-EMT Phenotype Associated with Altered Global Methylation Patterns
by: Jenna Kitz, et al.
Published: (2021-11-01)

SCAND1 Reverses Epithelial-to-Mesenchymal Transition (EMT) and Suppresses Prostate Cancer Growth and Migration
by: Takanori Eguchi, et al.
Published: (2022-12-01)

Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives
by: Stefania Cocco, et al.
Published: (2020-06-01)

Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers
by: Irem Ozkan-Dagliyan, et al.
Published: (2020-06-01)

VCAM1 Promotes Tumor Cell Invasion and Metastasis by Inducing EMT and Transendothelial Migration in Colorectal Cancer
by: Dan Zhang, et al.
Published: (2020-07-01)

Super-enhancer-associated SNHG15 cooperating with FOSL1 contributes to bladder cancer progression through the WNT pathway
by: Mingyue Tan, et al.
Published: (2023-11-01)

Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome
by: Luisa Benerini Gatta, et al.
Published: (2019-08-01)

Caveolin-1 promotes glioma proliferation and metastasis by enhancing EMT via mediating PAI-1 activation and its correlation with immune infiltrates
by: Zhaoxiang Wang, et al.
Published: (2024-01-01)

Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis
by: Hsin-Ling Yang, et al.
Published: (2019-05-01)

CYTOR Facilitates Formation of FOSL1 Phase Separation and Super Enhancers to Drive Metastasis of Tumor Budding Cells in Head and Neck Squamous Cell Carcinoma
by: Wenjin Wang, et al.
Published: (2024-01-01)

MCL1 Inhibition Overcomes the Aggressiveness Features of Triple-Negative Breast Cancer MDA-MB-231 Cells
by: Giovanni Pratelli, et al.
Published: (2023-07-01)

CircCRIM1 promotes nasopharyngeal carcinoma progression via the miR-34c-5p/FOSL1 axis
by: Weifeng He, et al.
Published: (2022-04-01)